Jun 15, 2026 09:01AM
Jun 15, 2026 09:00AM
Jun 18, 2024 11:35AM
Jun 18, 2024 11:35AM
May 22, 2023 09:00AM
May 22, 2023 09:00AM
Dec 13, 2021 08:46AM XBiotech (XBIT) IND for Natrunix Study Cleared by FDA
Dec 13, 2021 08:00AM
Dec 13, 2021 08:00AM
Apr 19, 2021 09:31AM
Apr 19, 2021 05:50AM
Apr 19, 2021 04:00AM
Apr 19, 2021 04:00AM
Jan 21, 2021 08:18AM XBiotech (XBIT) announces COVID-19 candidate True Human antibody therapy may also be used for treating COVID-19 mutant virus
Jan 21, 2021 08:15AM
Jan 21, 2021 08:15AM
Nov 19, 2020 08:16AM
Nov 19, 2020 08:15AM
Nov 19, 2020 08:15AM
Aug 24, 2020 09:31AM
Aug 24, 2020 08:41AM Convalescent Plasma Stocks Surge as FDA Issue Emergency Use Authorization
Aug 24, 2020 08:11AM
Aug 24, 2020 08:10AM
Aug 24, 2020 08:10AM
Apr 3, 2020 04:53PM
Apr 3, 2020 04:53PM
Oct 23, 2019 08:15AM
Oct 23, 2019 08:15AM XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa
Jul 10, 2019 08:00AM
Jul 10, 2019 08:00AM
Jun 25, 2019 08:45AM
Jun 25, 2019 08:45AM
May 23, 2019 08:23AM
May 23, 2019 08:20AM
May 23, 2019 08:20AM XBiotech Announces Plan to Launch Randomized Phase 2b Study of Bermekimab in Hidradenitis Suppurativa
Mar 5, 2019 08:17AM
Mar 5, 2019 08:15AM
Mar 5, 2019 08:15AM
Mar 1, 2019 11:46AM
Mar 1, 2019 11:44AM
Mar 1, 2019 11:44AM
Jan 23, 2019 08:34AM XBiotech (XBIT) Announces Bermekimab Successfully Treats Hidradenitis Suppurativa
Jan 23, 2019 08:30AM
Jan 23, 2019 08:30AM
Dec 12, 2018 08:32AM
Dec 12, 2018 08:30AM
Dec 12, 2018 08:30AM
Oct 31, 2018 04:05PM
Oct 31, 2018 04:05PM XBiotech Highlights Third Quarter Developments for 2018
Sep 26, 2018 09:28AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All